Concepedia

A. Makriyannis

AM

Statistics

Publications

34

Citations

2.2K

H-Index

25

Active since

1994

Affiliations

University of Connecticut(Current)

Northeastern University

University of Bonn

University of Calgary

Indiana University Bloomington

A. Makriyannis is an author at University of Connecticut specializing in pharmacology, neuropharmacology, and medicine.

Publications per year

1994–2022

34

Publications

34

Dopaminergic Modulation of Effort-Related Choice Behavior as Assessed by a Progressive Ratio Chow Feeding Choice Task: Pharmacological Studies and the Role of Individual Differences

Patrick A. Randall, Marta Pardo, Eric J. Nunes et al. · PLoS ONE · 2012 · 196 citations · Full text

Medicine, Neuroscience, Pharmacology +17

A novel peripherally restricted cannabinoid receptor antagonist, AM6545, reduces food intake and body weight, but does not cause malaise, in rodents

NL Cluny, VK Vemuri, AP Chambers et al. · British Journal of Pharmacology · 2010 · 191 citations · Full text

Medicine, Neuroscience, Pharmacology +14

Structure and Orientation of the Pore-forming Peptide Melittin, in Lipid Bilayers

R. Smith, Frances Separovic, Trudy J. Milne et al. · Journal of Molecular Biology · 1994 · 165 citations

Natural Sciences, Biochemistry, Biophysics +14

The cannabinoid CB1 antagonists SR 141716A and AM 251 suppress food intake and food-reinforced behavior in a variety of tasks in rats

Peter McLaughlin, Keisha M. Winston, Lynn A. Swezey et al. · Behavioural Pharmacology · 2003 · 164 citations

Medicine, Nutritional Sciences, Pharmacology +15

The Novel Cannabinoid CB1 Receptor Neutral Antagonist AM4113 Suppresses Food Intake and Food-Reinforced Behavior but Does not Induce Signs of Nausea in Rats

Kelly S. Sink, Peter McLaughlin, Jodi Wood et al. · Neuropsychopharmacology · 2007 · 160 citations · Full text

Medicine, Neuroscience, Pharmacology +11

1–5 of 34